About Janssen in Belgium
Janssen chooses to develop treatments for some of the most devastating disorders and complex medical challenges of our times. Read more
As a company Janssen is committed to providing regular updates on innovation and sustainability progress. The new Report to Society provides essential updates for its stakeholders to see where the company stands each year. It also stimulates the... Read more
Johnson & Johnson today named Dr. Bert Vogelstein of Johns Hopkins University, Johns Hopkins Kimmel Cancer Center and the Howard Hughes Medical Institute, the winner of the 2015 Dr. Paul Janssen Award for Biomedical Research for his... Read more
Researchers at UGent have managed to reduce the time needed for environmental sustainability analyses in drug production from 6 months to ‘the touch of a button’. This new method enables Janssen to determine the sustainability of its... Read more
The Prix Galien goes to Sirturo® (bedaquiline), a groundbreaking new antibiotic, developed by Janssen-researchers in Belgium for the treatment of drug-resistant tuberculosis. This innovative medicine is the first drug in many decades1 with an... Read more
What to expect from big data in life sciences?
Over the past days an international group of big data experts from the academic world, the government and industry gathered in Brussels for a conference about big... Read more